Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shot up 1.9% on Wednesday . The company traded as high as $5.86 and last traded at $5.84. 420,424 shares were traded during trading, a decline of 72% from the average session volume of 1,499,807 shares. The stock had previously closed at $5.73. Analyst Ratings Changes A […]
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 454,208 shares traded hands during mid-day trading, a decline of 69% from the previous session’s volume of 1,481,910 shares.The stock last traded at $5.96 and had previously closed at $5.81. Wall Street Analyst Weigh In Several research analysts recently […]
Connor Clark & Lunn Investment Management Ltd. raised its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 27.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 492,304 shares of the company’s stock after buying an additional 107,090 shares […]
Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have received a consensus rating of “Moderate Buy” from the five ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 […]
Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price […]